Piper Sandler & Co. Oyster Point Pharma, Inc. Transaction History

Piper Sandler & Co.

  • $161,000
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$17.83 - $29.12 $8,915 - $14,560
-500 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$27.86 - $35.93 $13,930 - $17,965
500 New
500 $14,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Piper Sandler & Co. Portfolio

Follow Piper Sandler & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piper Sandler & Co., based on Form 13F filings with the SEC.

News

Stay updated on Piper Sandler & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email